KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Common Equity (2016 - 2025)

Historic Common Equity for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $48.9 billion.

  • Medtronic's Common Equity rose 28.94% to $48.9 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $48.9 billion, marking a year-over-year increase of 28.94%. This contributed to the annual value of $48.3 billion for FY2025, which is 429.19% down from last year.
  • As of Q4 2025, Medtronic's Common Equity stood at $48.9 billion, which was up 28.94% from $48.1 billion recorded in Q3 2025.
  • Medtronic's Common Equity's 5-year high stood at $52.8 billion during Q3 2022, with a 5-year trough of $48.1 billion in Q3 2025.
  • Its 5-year average for Common Equity is $50.9 billion, with a median of $51.6 billion in 2021.
  • In the last 5 years, Medtronic's Common Equity skyrocketed by 366.29% in 2021 and then plummeted by 624.15% in 2024.
  • Quarter analysis of 5 years shows Medtronic's Common Equity stood at $52.2 billion in 2021, then decreased by 0.2% to $52.1 billion in 2022, then decreased by 0.79% to $51.6 billion in 2023, then decreased by 5.68% to $48.7 billion in 2024, then increased by 0.29% to $48.9 billion in 2025.
  • Its Common Equity was $48.9 billion in Q4 2025, compared to $48.1 billion in Q3 2025 and $48.3 billion in Q2 2025.